Log in
Enquire now
Portola Pharmaceuticals

Portola Pharmaceuticals

A company developing therapeutics for the treatment of acute and chronic cardiovascular and autoimmune and inflammatory diseases

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
Acquisition Transaction
Alexion Pharmaceuticals
Alexion Pharmaceuticals
0
AngelList URL
angel.co/portola-ph...maceuticals
B2X
B2B
B2B
0
CEO
‌
William Lis
Legal Name
Portola Pharmaceuticals, Inc.
Company Operating Status
Closed
Crunchbase URL
crunchbase.com/organiz...euticals
DUNS Number
142296016
Founded Date
2003
Full Address
270 East Grand Ave., South San Francisco, CA 94080, US
Industry
Autoimmune disease
Autoimmune disease
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Investors
Lightstone Ventures
Lightstone Ventures
0
‌
Eastern Capital
Temasek
Temasek
Brookside Capital
Brookside Capital
Latest Funding Round Date
November 21, 2011
Latest Funding Type
Series D
Series D
LinkedIn URL
@company/portola-pharmaceuticals
Location
South San Francisco, California
South San Francisco, California
Number of Employees (Ranges)
201 – 500
Patents Assigned (Count)
59
Public/Private
Public
Exchange
Nasdaq
Nasdaq
Stock Symbol
PTLA
Total Funding Amount (USD)
89,000,000
Twitter URL
@portola_pharma
Official Website
portola.com
Wellfound ID
portola-pharmaceuticals

Find more companies like Portola Pharmaceuticals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.